Sort   by:  
 Page size 
UnknownImmunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.
Not available
S-EPMC4178794 | biostudies-literature
UnknownPre-existing T Cell Memory against Zika Virus.
Not available
S-EPMC8316092 | biostudies-literature
UnknownThe human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes.
Not available
S-EPMC4301095 | biostudies-literature
UnknownHuman CD4+ T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity.
Not available
S-EPMC5309943 | biostudies-literature
UnknownPatterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain.
Not available
S-EPMC5375662 | biostudies-literature
UnknownIdentification of immunogenic and cross-reactive chikungunya virus epitopes for CD4<sup>+</sup> T cells in chronic chikungunya disease.
Not available
S-EPMC12218217 | biostudies-literature
UnknownChikungunya virus-specific CD4<sup>+</sup> T cells are associated with chronic chikungunya viral arthritic disease in humans.
Not available
S-EPMC12147901 | biostudies-literature
UnknownHumoral and cellular immune memory to four COVID-19 vaccines.
Not available
S-EPMC9135677 | biostudies-literature
UnknownSafety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial.
Not available
S-EPMC11672239 | biostudies-literature
UnknownHeterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial.
Not available
S-EPMC9126042 | biostudies-literature
Sort   by:  
 Page size